510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K151809Substantially Equivalent

Alere Afinion HbA1c, Alere Afinion AS100 Analyzer

Alere Technologies AS, Oslo, NO / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K151809 is the FDA 510(k) clearance record for Alere Afinion HbA1c, Alere Afinion AS100 Analyzer, a class II device, cleared for Alere Technologies AS on under FDA product code LCP (Assay, Glycosylated Hemoglobin). FDA records list 3 510(k) clearances for Alere Technologies AS, from to . As of , FDA records show no recalls naming K151809.

Clearance record

Decision date
Received
(85 days to decision)
Product code
LCP Assay, Glycosylated Hemoglobin
Regulation
21 CFR 864.7470
Device class
Class II
Review panel
Hematology
Applicant
Alere Technologies AS Kjelsaasveien 161, Oslo, NO
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LCP

Trailing 12 months

FDA records hold no clearances under product code LCP in the trailing twelve months.

FDA records show no clearances under product code LCP in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LCP, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260